Keywords: adrenomedullin; hormone; peptide belongs to the CGRP superfamily. The human ADM precursor (preproADM ) is 185 amino acids in length and is processed to 164-amino acid peptide, proADM, and then to a 52-amino acid peptide, the biologically active form of ADM. The genomic DNA of human
Introduction
ADM consists of 4 exons and 3 introns, and the fourth exon codes for the mature form of ADM [5] . There are also multiple binding sites for activator protein-2 In 1993, Kitamura et al. discovered a novel hypotensive and a cAMP-regulated enhancer element. The ADM factor by means of monitoring the ability of extracted gene is located in a single locus of chromosome 11. fractions of human pheochromocytoma to increase platelet cyclic adenosine 3∞,5∞-monophosphate (cAMP) [1] . This factor is named adrenomedullin (ADM ), as Distribution and synthesis of ADM in the kidney it is abundant in normal adrenal medulla as well as in pheochromocytoma. ADM is a 52-amino acid peptide ADM immunoreactivities and gene expressions are with a ring structure and C-terminal amidation. ADM widely distributed in mammalian tissues, including mediates vasodilating properties through cAMP and kidney. We have demonstrated immunohistochemical nitric oxide (NO). ADM immunoreactivity and gene stainings for ADM in glomeruli, cortical distal tubules expressions are widely distributed in mammalian and medullary collecting duct cells [2] . We also found organs, including the kidney [2, 3] . ADM is present in that ADM was present in mesangial cells and microvashuman plasma and urine, and urinary levels are higher cular areas of rat glomeruli [3] . The intensities of than plasma levels, indicating that the kidney may be ADM immunoreactivity in the glomerulus, distal one of the major organs for ADM production [4] . In tubules and medullary collecting duct cells were addition to the vasodilating effect, ADM has diuretic increased in the canine model of congestive heart and natriuretic actions, which are mediated by failure as compared with normal dogs, suggesting renal increases in glomerular filtration rate (GFR) and a activation of ADM in congestive heart failure [6 ] . decrease in distal tubular sodium reabsorption [2] . Other investigators reported that ADM mRNA was Clinically, plasma ADM levels are increased in patients expressed in the glomerulus, cortical collecting duct with chronic renal failure. Current observations suggest cells, outer collecting duct cells and inner collecting that ADM plays an important role in renal regulation duct cells using the reverse transcription-polymerase including fluid and electrolyte homeostasis. In this chain reaction (RT-PCR) technique [7] . Northern blot paper, we focus on the study of ADM in the kidney, analysis revealed high expression of ADM mRNA in and review the current knowledge about renal ADM mesangial cells [7] . In-situ hybridization also showed research.
ADM gene expression in the glomerulus and cortical distal tubules [8] .
Although it is established that ADM is synthesized
Structure and molecular biology of ADM
and secreted from vascular endothelial and smooth muscle cells, ADM is also synthesized and secreted from cultured mesangial cells [3, 9] . ADM is detected ADM consists of 52 amino acids and has a unique in human urine, and urinary ADM levels are much 6-amino acid residue ring structure and C-terminal higher than plasma levels, suggesting that kidney may amidation, which is similar to calcitonin gene related be one of the major tissues for ADM production [4] . peptide (CGRP) and amylin. Actually, ADM shows 27% homology with CGRP, suggesting that ADM
ADM receptor in the kidney
Correspondence and offprint requests to: Michihisa Jougasaki, MD, PhD, Cardiorenal Research Laboratory, Mayo Clinic and indicating the presence of a specific receptor for ADM tured rat mesangial cells and cell proliferation in a concentration-dependent manner [23] . ADM also in the kidney [10] . Edwards et al. reported that the effects of the CGRP antagonist, CGRP 8-37 on ADM-inhibited endothelin-1-induced activation of MAPK in cultured mesangial cells [24] . mediated cAMP generation were different between the glomeruli and distal convoluted tubules in the kidney [11] . CGRP 8-37 had no effect on ADM-mediated Renin release increases in cAMP in the glomeruli, however CGRP 8-37 Intravenous administrations of ADM in conscious inhibited ADM-mediated increases in cAMP in the rabbits [25] and conscious sheep [26 ] resulted in a distal convoluted tubules. These findings suggested decrease in mean arterial blood pressure and an that glomeruli have 'ADM-like' receptors that have a increase in plasma renin activity. Jensen et al. investihigh affinity for ADM but a low affinity for CGRP gated the effect of ADM on renin secretion and renin and CGRP 8-37
, whereas the distal convoluted tubules gene expression in renal juxtaglomerular granular cells have 'CGRP-like' receptors with a high affinity for [27] . Renin release from isolated perfused rat kidney CGRP and CGRP 8-37 but a low affinity for ADM. was dose-dependently increased by ADM. In primary Recently, McLatchie et al. reported that the calcitonin-cultures of mouse granular cells ADM augmented receptor-like receptor (CRLR) with seven transmem-renin release, renin mRNA accumulation and cAMP brane domains and receptor-activity-modifying protein production in a concentration-and time-dependent 2 (RAMP 2 ) with single transmembrane domain gener-manner. ADM may act as an autocrine and/or paracated an ADM receptor [12] . RAMP 2 plays a role in rine stimulatory factor in the regulation of renin secretransporting CRLR to the plasma membrane.
tion and renin gene expression. However, other investigators reported that chronically infused ADM had a hypotensive effect accompanied by significant
Renal physiology
reductions of plasma renin activity in conscious twokidney, one-clip hypertensive and sham-operated rats Actions on the renal vessels [28] . ADM is a potent vasodilator in the regulation of vascular tone. In organ chamber studies, ADM induced
Clinical implications in renal diseases
a concentration-dependent vasodilatation in canine renal arteries [13] . The vasodilating effects were slightly Plasma ADM concentration was increased in patients greater in endothelium-intact arteries than in denuded with chronic renal failure [4, [29] [30] [31] . There was a arteries. ADM elicited a concentration-dependent positive correlation between circulating ADM and vasodilating response which was blocked by CGRP 8-37 plasma creatinine levels [29] . There was also a positive in the rat isolated perfused kidney [14] .
correlation between plasma ADM concentration and mean arterial blood pressure in both patients before Natriuretic actions haemodialysis and healthy subjects [30] . However, We have elucidated that ADM is a new natriuretic plasma ADM concentration was not altered by haemopeptide [2] . Intrarenal infusion of ADM resulted in dialysis [4, 30] . marked diuretic and natriuretic responses, which were associated with an increase in GFR and a decrease in ProADM N-terminal 20 peptide (PAMP) distal tubular sodium reabsorption. ADM-mediated natriuresis was completely abolished by inhibition of In addition to ADM, the precursor of ADM prostaglandin synthesis [15] .
(proADM ) contains another vasodilating peptide, Other investigators also reported that ADM pronamed proADM N-terminal 20 peptide (PAMP) in its duced natriuretic actions in dogs [16, 17] and in rats N-terminal portion. Interestingly, the C-terminus of [18] [19] [20] . The renal response to ADM was attenuated PAMP is amidated like ADM. Tissue localization of by inhibition of NO synthesis, indicating that renal PAMP is similar to that of ADM, supporting the vasodilating, diuretic and natriuretic responses to theory that its origin is in the same gene as ADM. The ADM may be mediated by the release of endogenous mechanism of vasodilatation induced by PAMP is NO [17, 21] . Hirata et al. directly showed that ADM different from that induced by ADM. Shimosawa et al. increased the release of endogenous NO in the isolated reported that PAMP inhibits neural transmission at kidney utilizing chemiluminescence assay [19] .
peripheral sympathetic nerve endings [32] . PAMP is present in plasma and its plasma concentration is Mesangial cell proliferation increased in patients with chronic renal failure [33] . ADM inhibited the proliferation of mesangial cells, and ADM decreased the activation of mitogenConclusion activated protein kinase (MAPK ) induced by plateletderived growth factor (PDGF ), indicating that ADM can suppress mesangial cell mitogenesis [22] . ADM ADM is a 52-amino acid vasodilating and natriuretic peptide, originally isolated in human pheochromocytoma. inhibited both [3H ]thymidine incorporation into cul-
